A further study, in a mouse MCAO model, found that the anti-inflammatory bioactive alkaloid sinomenine, was able to reduce inflammatory processes after the stroke, and that this was mediated through an increase in D2R expression on astrocytes, as well as an increase in αB-crystallin levels (Qiu et al., 2016). This evidence concerns the gene DRD2 and Stroke.